# Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)

> **NCT02707042** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 108 (actual)

## Conditions studied

- Normal Physiology
- Healthy

## Interventions

- **DRUG:** Amoxicillin
- **DRUG:** Azithromycin
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT02707042
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-22
- **Primary completion:** 2025-05-14
- **Final completion:** 2025-05-15
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2025-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02707042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02707042, "Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02707042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*